ribavirin has been researched along with uridine in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (35.29) | 18.7374 |
1990's | 1 (5.88) | 18.2507 |
2000's | 2 (11.76) | 29.6817 |
2010's | 8 (47.06) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Hong, J; Johnson, ZL; Kwon, DY; Lee, JH; Lee, K; Lee, M; Lee, SY | 1 |
Browne, MJ | 1 |
Allen, LB; Cook, PD; Holland, CS; Kehoe, MJ; McNamara, DJ; Teepe, AG | 1 |
Lee, HJ; Nguyen, BT; Pawlak, K; Robins, RK; Sadée, W | 1 |
Cysyk, RL; Mao, DT; Marquez, VE; Monks, A | 1 |
Cysyk, RL; Karle, JM; Monks, A; Wolfe, RM | 1 |
Hyman, DS; Knight, V; Koff, WC; Peavy, DL | 1 |
Glue, P; Jarvis, SM; Thorn, JA | 1 |
Cass, CE; Damaraju, VL; Jayaram, HN; Mowles, D; Ng, AM; Visser, F; Young, JD; Zhang, J | 1 |
Carlson, EJ; Ferrin, TE; Giacomini, KM; Gray, JH; Huang, CC; Johns, SJ; Kawamoto, M; Owen, RP; Stryke, D; Taylor, TR | 1 |
Kimura, E; Nagai, J; Suzuki, S; Takano, M; Yumoto, R | 1 |
Drexler, DM; Grace, JE; Wei, C; Zvyaga, TA | 1 |
Felczak, K; Metselaar, HJ; Pan, Q; Pankiewicz, KW; Peppelenbosch, MP; Raat, NJ; Shokrollahi, E; Sprengers, D; van der Laan, LJ; Wang, W; Wang, Y; Xu, L; Zhou, X | 1 |
Almasio, PL; Barr, E; Bruno, S; Buti, M; Butterton, JR; Dutko, FJ; Fernsler, D; Gao, W; Grandhi, A; Hassanein, TI; Huang, HC; Jancoriene, L; Lawitz, E; Li, JJ; Liu, H; Muellhaupt, B; Nguyen, BT; Pearlman, B; Plank, RM; Robertson, MN; Ruane, PJ; Shepherd, A; Su, FH; Tannenbaum, B; Vierling, JM; Wahl, J; Wan, S; Yeh, WW; Yoshida, EM | 1 |
Brainard, DM; Curtis, C; Lasseter, K; Lawitz, E; Ling, KHJ; Marbury, T; Mathias, A; Mogalian, E; Moorehead, L; Murray, B; Osinusi, A; Perry, R | 1 |
Barr, E; Burnevich, E; Buti, M; Feld, JJ; Foster, GR; Gane, E; Hanna, GJ; Jackson, B; Katchman, H; Klopfer, S; Lahser, F; Lawitz, E; Platt, HL; Rabinovitz, M; Robertson, MN; Shaughnessy, M; Tomasiewicz, K; Yeh, WW | 1 |
3 trial(s) available for ribavirin and uridine
Article | Year |
---|---|
Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and without cirrhosis with chronic hepatitis C virus genotype 1, 2, or 3 infection (C-CREST-1 and C-CREST-2,
Topics: Adult; Amides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Administration Schedule; Female; Genotype; Hepatitis C, Chronic; Heterocyclic Compounds, 4 or More Rings; Humans; Liver Cirrhosis; Male; Middle Aged; Pyrrolidines; Quinoxalines; Ribavirin; Sulfonamides; Sustained Virologic Response; Thiazoles; Uridine | 2017 |
Pharmacokinetics and Safety of Velpatasvir and Sofosbuvir/Velpatasvir in Subjects with Hepatic Impairment.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Carbamates; Drug Combinations; Drug Therapy, Combination; Female; Hepatic Insufficiency; Hepatitis C; Heterocyclic Compounds, 4 or More Rings; Humans; Liver Cirrhosis; Male; Middle Aged; Ribavirin; Sofosbuvir; Uridine; Young Adult | 2018 |
Efficacy and safety of a two-drug direct-acting antiviral agent regimen ruzasvir 180 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4, 5 or 6.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Heterocyclic Compounds, 4 or More Rings; Humans; Interferons; Male; Middle Aged; Pyrrolidines; Ribavirin; RNA, Viral; Sustained Virologic Response; Thiazoles; Uridine; Young Adult | 2019 |
14 other study(ies) available for ribavirin and uridine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Structural basis of nucleoside and nucleoside drug selectivity by concentrative nucleoside transporters.
Topics: Animals; Bacterial Proteins; Binding Sites; Biological Transport; Crystallography, X-Ray; Deoxycytidine; Female; Gemcitabine; Gene Expression; Humans; Kinetics; Membrane Transport Proteins; Molecular Docking Simulation; Nucleoside Transport Proteins; Oocytes; Protein Binding; Quantitative Structure-Activity Relationship; Recombinant Proteins; Ribavirin; Substrate Specificity; Thermodynamics; Uridine; Vibrio cholerae; Xenopus laevis | 2014 |
Mechanism and specificity of action of ribavirin.
Topics: Animals; Cell Line; Dogs; Guanosine; Influenza A virus; Inosine; Kidney; Protein Biosynthesis; Ribavirin; Ribonucleosides; Uridine; Viral Proteins | 1979 |
Antiviral and cytotoxicity evaluation of 3-nitro-3-deazauridine.
Topics: 3-Deazauridine; Animals; Antiviral Agents; Cells, Cultured; Drug Evaluation; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Ribavirin; RNA Viruses; Uridine | 1989 |
Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
Topics: Adenosine Triphosphate; Animals; Cell Division; Cells, Cultured; DNA, Neoplasm; Guanine; Guanylate Kinases; Hypoxanthine Phosphoribosyltransferase; IMP Dehydrogenase; Ketone Oxidoreductases; Lymphoma; Mice; Mycophenolic Acid; Nucleoside-Diphosphate Kinase; Nucleoside-Phosphate Kinase; Organoselenium Compounds; Ribavirin; Ribonucleosides; RNA, Neoplasm; Selenium; Tritium; Uridine | 1985 |
Uptake of 2-beta-D-ribofuranosylthiazole-4-carboxamide (tiazofurin) and analogues by the facilitated transport mechanism of erythrocytes.
Topics: Antineoplastic Agents; Biological Transport; Carbon Radioisotopes; Erythrocytes; Humans; In Vitro Techniques; Kinetics; Nucleosides; Ribavirin; Ribonucleosides; Structure-Activity Relationship; Uridine | 1985 |
Effect of 2-beta-D-ribofuranosylthiazole-4-carboxamide on uptake of nucleosides by cultured L1210 cells.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Leukemia L1210; Nucleosides; Ribavirin; Ribonucleosides; Uridine | 1984 |
Inhibition of lymphocyte proliferative responses by ribavirin.
Topics: Cells, Cultured; Concanavalin A; DNA; Humans; Leucine; Lymphocyte Activation; Lymphocytes; Ribavirin; Ribonucleosides; Uridine | 1980 |
Ribavirin uptake by human erythrocytes and the involvement of nitrobenzylthioinosine-sensitive (es)-nucleoside transporters.
Topics: Adenosine; Animals; Antiviral Agents; Carrier Proteins; Equilibrative-Nucleoside Transporter 2; Erythrocyte Membrane; Erythrocytes; Horses; Humans; In Vitro Techniques; Membrane Proteins; Ribavirin; Thioinosine; Uridine | 1998 |
Role of human nucleoside transporters in the cellular uptake of two inhibitors of IMP dehydrogenase, tiazofurin and benzamide riboside.
Topics: Animals; Biological Transport; Cell Survival; Female; Humans; IMP Dehydrogenase; Membrane Transport Proteins; Nucleosides; Oocytes; Protein Isoforms; Recombinant Proteins; Ribavirin; Saccharomyces cerevisiae; Uridine; Xenopus laevis | 2005 |
Genetic analysis and functional characterization of polymorphisms in the human concentrative nucleoside transporter, CNT2.
Topics: Alleles; Animals; Antiviral Agents; Cytoplasm; DNA; Dose-Response Relationship, Drug; Exons; Genetic Variation; Guanosine; Haplotypes; Humans; Inhibitory Concentration 50; Inosine; Kinetics; Membrane Transport Proteins; Models, Genetic; Nucleoside Transport Proteins; Nucleosides; Oocytes; Plasmids; Polymorphism, Genetic; Ribavirin; Sensitivity and Specificity; Uridine; Xenopus laevis | 2005 |
Human erythrocyte nucleoside transporter ENT1 functions at ice-cold temperatures.
Topics: Cold Temperature; Dose-Response Relationship, Drug; Equilibrative Nucleoside Transporter 1; Erythrocyte Membrane; Glucose Transporter Type 1; Humans; Ribavirin; Thioinosine; Uridine | 2010 |
Utility of high-resolution accurate MS to eliminate interferences in the bioanalysis of ribavirin and its phosphate metabolites.
Topics: Adenosine Monophosphate; Antiviral Agents; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Glucuronosyltransferase; Hepatitis C, Chronic; Humans; Nucleotides; Ribavirin; Spectrometry, Mass, Electrospray Ionization; Uridine; Uridine Diphosphate; Uridine Monophosphate | 2012 |
Cross Talk between Nucleotide Synthesis Pathways with Cellular Immunity in Constraining Hepatitis E Virus Replication.
Topics: Antiviral Agents; Cell Line, Tumor; Guanosine; Hepatitis E virus; Humans; Immunity, Cellular; IMP Dehydrogenase; Interferon-alpha; Mycophenolic Acid; Nucleotides; Ribavirin; Uridine; Virus Replication | 2016 |